| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 143.965 | 127.968 | 158.432 | 155.406 | 156.221 | 172.186 | 220.985 | 286.022 | 191.253 | 229.711 |
| Total Income - EUR | 148.196 | 149.895 | 151.578 | 158.424 | 164.269 | 180.803 | 239.369 | 299.338 | 205.976 | 246.539 |
| Total Expenses - EUR | 144.307 | 142.619 | 133.468 | 134.745 | 119.965 | 134.958 | 176.252 | 237.014 | 262.132 | 237.230 |
| Gross Profit/Loss - EUR | 3.890 | 7.276 | 18.110 | 23.680 | 44.304 | 45.845 | 63.117 | 62.323 | -56.156 | 9.309 |
| Net Profit/Loss - EUR | 2.965 | 5.686 | 9.791 | 20.052 | 42.572 | 44.342 | 61.091 | 59.646 | -57.982 | 3.991 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Anagralan Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 128.654 | 120.045 | 97.912 | 86.952 | 131.568 | 106.856 | 147.151 | 142.135 | 131.101 | 97.380 |
| Current Assets | 44.060 | 26.670 | 16.637 | 8.342 | 42.779 | 23.895 | 36.058 | 39.376 | 6.447 | 24.729 |
| Inventories | 2.014 | 16.389 | 6.413 | 6.464 | 21.093 | 6.074 | 7.278 | 6.083 | 10.652 | 19.096 |
| Receivables | 30.032 | 14.524 | 17.617 | 5.996 | 15.335 | 4.346 | 926 | 809 | 3.784 | 16.801 |
| Cash | 12.014 | -4.244 | -7.392 | -4.118 | 6.350 | 13.475 | 27.854 | 32.484 | -7.989 | -11.168 |
| Shareholders Funds | 58.004 | 5.739 | 15.432 | 20.104 | 42.623 | 44.391 | 61.140 | 59.694 | -57.933 | -53.619 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 114.710 | 140.975 | 99.117 | 75.191 | 131.724 | 86.360 | 122.069 | 121.817 | 195.482 | 175.728 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "111 - 111" | |||||||||
| CAEN Financial Year |
111
|
|||||||||
Comments - Anagralan Srl